GlobeNewswire

Iconic Tech Event from Silicon Valley is Coming to Europe in June 2018

Dela

PALO ALTO, Calif., April 19, 2018 (GLOBE NEWSWIRE) -- Intellectsoft, global software development company with a focus on the latest tech, will co-host "Blockchain: Rethink Trust 2018" - a new, enterprise-grade conference on blockchain engineering that is a part of By the Bay event series, well-known in the Silicon Valley. The event will take place in Amsterdam at the historic venue Beurs van Berlage on Friday, June 29.

The conference will challenge the traditional understanding of blockchain and corporate world, gathering top engineers, C-level executives, and blockchain enthusiasts. The event will cover topics like integration and adoption of blockchain across key industries, properties of blockchain protocols, distributed systems in Big Data, and have coding workshops on building Hyperledger and blockchain solutions.

"Blockchain: Rethink Trust 2018" will be keynoted by executive leaders from IBM and ING and feature top tech talent from around the world in Internet of Things (IoT), energy, fintech, and other industries. The conference's attendees will share their experiences of the best ways to monetize blockchain, discuss regulatory trends, and facilitate strategic partnerships for consortium private blockchain development.

The event is led by Intellectsoft Blockchain Lab, consulting and development unit that offers access to a wide pool of engineering, cryptography, and cybersecurity talent in Eastern Europe.

To learn about Blockchain: Rethink Trust conference - visit  rethinktrust.org

About Intellectsoft

Intellectsoft is a global full-cycle software engineering company that helps businesses to overcome technology challenges of digital transformation through use of emerging technologies like Cognitive Computing, Decentralized Applications, IoT, and Augmented Reality.

The company's service portfolio includes strategic IT consulting, CX design, development and full lifecycle management of custom products in integrated systems. Established in 2007, Intellectsoft operates in multiple offices and engineering centers in the US, the UK, the Nordic region, and Eastern Europe. The company's headquarters are located in Palo Alto, California. blockchain.intellectsoft.net

About By the Bay

By the Bay has been organizing big-scale tech events in San Francisco Bay Area for over 5 years. During this time, the company had formed data engineering and data science communities that focus on learning, open-source excellence, and industry-oriented approaches.

With respected tech leaders taking stage, By the Bay events are always rich on insightful case studies about data, code, and their business value. Every event of the By the Bay series gathers 500 top-level executives and established experts. s cale.bythebay.io

Photos accompanying this announcement are available at

http://resource.globenewswire.com/Resource/Download/744d677f-43e8-4e62-8a1c-5467e4290b53

http://resource.globenewswire.com/Resource/Download/ea5c2ba6-fdbe-4968-9917-fadc1774ae5a

 

Contact:
Val Litvin
Head of Marketing | Intellectsoft
E: valery.litvin@intellectsoft.net 
W: www.intellectsoft.net 



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Intellectsoft via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Corline Biomedical AB: Patientrekrytering startar i Renaparin-studie30.11.2018 16:37Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att patientrekrytering i den kliniska fas 1-studien RENAPAIR-01 startar. I studien utvärderas bolagets läkemedelskandidat Renaparin® som är under utveckling för att förbättra utfallet av njurtransplantation. Patienter kommer inledningsvis att rekryteras på Akademiska sjukhuset i Uppsala. När de fyra första patienterna utvärderats inleds också rekrytering på Karolinska Universitetssjukhuset i Huddinge. Beskedet att patientrekrytering startar innebär att förberedelsearbetet inför studiestart är avslutat och att till exempel avtal, initieringsmöte, logistik, provhantering och monitorering är hanterat, samt att godkänt prövningsläkemedel nu finns tillgängligt för rekvirering av kirurgerna på transplantationskliniken i Uppsala för dosering till donatornjurar. När första patient doserats kommer detta meddelas separat. Corline har utvecklat och äger rättigheterna till Renaparin® som administreras direkt till den donerade njuren i

Stillfront: Bytro Labs lanserar en ny version av Supremacy 191427.11.2018 08:00Pressmeddelande

PRESSMEDDELANDE 2018-11-27 Bytro Labs, en studio inom Stillfront Group, lanserar en ny version av Supremacy 1914 Spelutvecklaren Bytro Labs, mest kända för sitt framgångsrika strategispel Call of War, har släppt en ny version av sin klassiska speltitel Supremacy 1914. Dagens lansering är den första av tre milstolpar för den nya versionen av Supremacy 1914 - The Great War som släpps 2019. Den första uppdateringen innehåller en komplett omarbetning av området för spelets community, ett nytt utseende för kartan samt ny 3D-teknologi. I nästa steg kommer Bytro Labs att gå vidare till "true cross platform" där spelet tillgängliggörs för fler plattformar, en strategi som tidigare har varit framgångsrik för titeln Call of War. Supremacy 1914 - The Great War släpps för Android senare i år och i början av 2019 släpps spelet för iOS och Steam. Det tredje och sista steget i lanseringen kommer i mitten av 2019 innehållande en större uppdatering avseende både innehåll och funktion, som färdigställer

Stillfront: Bytro Labs releases a new version of Supremacy 191427.11.2018 08:00Pressmeddelande

PRESS RELEASE November 27, 2018 Bytro Labs, part of Stillfront Group, releases a new version of Supremacy 1914 Online games developer Bytro Labs, best known for its grand strategy hit Call of War, has released a new version of their classic title Supremacy 1914. Today's release marks the first of three milestones for the new version Supremacy 1914 - The Great War in 2019. This first update features a completely reworked community area, a new map look and a new 3D rendering technology. In the next step Bytro Labs is further embracing its cross-platform strategy, which has already shown great success for Call of War. Supremacy 1914 - The Great War is releasing for Android phones later this year and is followed in early 2019 by iOS devices and leading PC gaming platform Steam. The third and final stage will be reached in mid-2019 with a major content and feature update, which will finalize Supremacy 1914 - The Great War and make the brand ready for the future ensuring its continued succes

Stillfront Group AB: eRepublik.com i mjuklansering för mobilen26.11.2018 12:26Pressmeddelande

PRESSMEDDELANDE 2018-11-26 eRepublik Labs, en studio inom Stillfront Group, mjuklanserar eRepublik.com för mobilen eRepublik.com firar 11 årsjubileum och lanseras för första gången mobilt. eRepublik Mobile finns tillgänglig som öppen beta version på Google Play early access program. Spelet förväntas befinna sig i mjuklansering i ett par månader. eRepublik.com är det första spelet som lanserades av eRepublik Labs 2007. Mer än tio miljoner människor har spelat spelet under dess elvaåriga historik. Spelet har som browser-version ett dedikerat community med mer än 35 000 månatliga unika spelare och intäkterna har stigit under året. eRepublik Mobile kommer att fungera i synkronisering med browser-versionen vilket betyder att både befintliga och nya spelare kommer att kunna spela på båda plattformarna nu. "eRepublik.com inledde vårt äventyr och var vårt största spel till dess att våra mobilspel, såsom War and Peace, lanserades. eRepublik är idag ett av våra fem huvudsakliga live-spel och tro

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum